Updated:
High Forest Investment
High Forest Investment is a venture capital firm that focuses on early-stage biopharmaceutical companies. Their investments are made in the primary market,...
High Forest Investment
High Forest Investment is a venture capital firm that focuses on early-stage biopharmaceutical companies. Their investments are made in the primary market, with a particular emphasis on gene therapy and mRNA therapeutics. The firm operates on a global scale, seeking opportunities in the biopharmaceutical sector.
General information
Firm type
Venture Capital
Location
Country
United Kingdom
Corporate office
United Kingdom
Sector focus
Frequently asked questions
What type of investments does High Forest Investment make?
High Forest Investment makes primary-market investments in early-stage biopharmaceutical companies.
What are the key focus areas for High Forest Investment?
The key focus areas for High Forest Investment are gene therapy and mRNA therapeutics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: